Literature DB >> 1849844

Endocrine pancreatic carcinoma.

M Rothmund1, B Stinner, R Arnold.   

Abstract

Endocrine carcinomas of the pancreas are rare, but they should be treated aggressively because they threaten the patient's life by both malignant growth and hormone excess. Resection for cure should be attempted, but is hardly ever possible. Debulking should be performed primarily in hormone-active tumours so that symptoms can be controlled by subsequent medical treatment; this can be directed against tumour growth and/or hormone production, and it can reduce stomach acid secretion in the gastrinoma syndrome. Surgery should be undertaken whenever possible since the patient's life can be considerably prolonged in most cases. Palliative surgery can reduce the patient's symptoms that may be caused by excessive hormone production and/or obstruction of the bile duct or the duodenum.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849844

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  5 in total

1.  CARCINOID SYNDROME.

Authors:  S Shankar; Rajat Kumar; S P Kalra; P S Reddy; S K Sharma; K S Rao; A Menon
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 2.  Long-term survival after diagnosis of hepatic metastatic VIPoma: report of two cases with disparate courses and review of therapeutic options.

Authors:  H N Nguyen; B Backes; F Lammert; J Wildberger; R Winograd; N Busch; H Rieband; S Matern
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

3.  Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.

Authors:  R Arnold; M E Trautmann; W Creutzfeldt; R Benning; M Benning; C Neuhaus; R Jürgensen; K Stein; H Schäfer; C Bruns; H J Dennler
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

Review 4.  Advances in the treatment of neuroendocrine tumors.

Authors:  Matthew Kulke
Journal:  Curr Treat Options Oncol       Date:  2005-09

5.  Surgical management of malignant islet cell tumors.

Authors:  C S Grant
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.